Literature DB >> 92595

The pathology of the Mongolian Gerbil (Meriones unguiculatus): a review.

A L Vincent, G E Rodrick, W A Sodeman.   

Abstract

Both naturally occurring disease processes and experimental models of human disease in the Mongolian gerbil were reviewed. The gerbil was highly susceptible to cerebral infarction following unilateral ligation of one common carotid artery and was useful in studies of the pathogenesis of stroke. Spontaneous epileptiform seizures mimicked those of human idiopathic epilepsy, and both seizure-sensitive and resistant strains have been bred. Perhaps because of its more efficient nephron, the gerbil accumulated four to six times as much renal lead as the rat, and the gerbil has been proposed as an experimental model of lead nephropathy. On standard diets, about 10% of the animals became obese, and some showed decreased glucose tolerance, elevated serum immunoreactive insulin and diabetic changes in the pancreas and other organs. Some breeders exhibited hyperactivity of the adrenal cortex associated with hyperglycemia, hyperlipidemia and degenerative vascular disease. Although dietary supplements of cholesterol were toxic and did not induce atherosclerosis, the gerbil was useful in other studies of cholesterol absorption and metabolism. Spontaneous, insidious periodontal disease became evident after about 6 months on standard diets, and dental caries were induced by cariogenic diets or by pathodontic streptococci. Spontaneous neoplasia occurred in 8.4--24% of gerbils, usually after 2 years of life. Adrenal cortical, ovarian and cutaneous tumors were the most consistently reported neoplasms.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92595

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  8 in total

Review 1.  Research-Relevant Conditions and Pathology of Laboratory Mice, Rats, Gerbils, Guinea Pigs, Hamsters, Naked Mole Rats, and Rabbits.

Authors:  Timothy K Cooper; David K Meyerholz; Amanda P Beck; Martha A Delaney; Alessandra Piersigilli; Teresa L Southard; Cory F Brayton
Journal:  ILAR J       Date:  2021-12-31       Impact factor: 1.521

2.  Undifferentiated Sarcoma of the Salivary Gland in a Mongolian Gerbil (Meriones unguiculatus).

Authors:  Takeshi Toyoda; Tetsuya Tsukamoto; Young-Man Cho; Saeko Onami; Shinji Takasu; Liang Shi; Ayumi Saito; Saori Matsuo; Masae Tatematsu; Akiyoshi Nishikawa; Kumiko Ogawa
Journal:  J Toxicol Pathol       Date:  2011-10-12       Impact factor: 1.628

3.  Obesity-induced diet leads to weight gain, systemic metabolic alterations, adipose tissue inflammation, hepatic steatosis, and oxidative stress in gerbils (Meriones unguiculatus).

Authors:  Luciana L A Ventura; Nathália C L Fortes; Helton C Santiago; Marcelo V Caliari; Maria A Gomes; Dirce R Oliveira
Journal:  PeerJ       Date:  2017-03-02       Impact factor: 2.984

Review 4.  From humans to hydra: patterns of cancer across the tree of life.

Authors:  Thales A F Albuquerque; Luisa Drummond do Val; Aoife Doherty; João Pedro de Magalhães
Journal:  Biol Rev Camb Philos Soc       Date:  2018-04-16

Review 5.  Anatomy and Disorders of the Oral Cavity of Rat-like and Squirrel-like Rodents.

Authors:  Elisabetta Mancinelli; Vittorio Capello
Journal:  Vet Clin North Am Exot Anim Pract       Date:  2016-09

6.  Odours of cancerous mouse congeners: detection and attractiveness.

Authors:  Flora Gouzerh; Bruno Buatois; Maxime R Hervé; Maicol Mancini; Antonio Maraver; Laurent Dormont; Frédéric Thomas; Guila Ganem
Journal:  Biol Open       Date:  2022-04-29       Impact factor: 2.643

7.  Inbred or Outbred? Genetic Diversity in Laboratory Rodent Colonies.

Authors:  Thomas D Brekke; Katherine A Steele; John F Mulley
Journal:  G3 (Bethesda)       Date:  2018-02-02       Impact factor: 3.154

8.  Generation of Gene-Knockout Mongolian Gerbils via CRISPR/Cas9 System.

Authors:  Yan Wang; Peikun Zhao; Zidai Song; Xiaoyan Du; Xueyun Huo; Jing Lu; Xin Liu; Jianyi Lv; Changlong Li; Meng Guo; Zhenwen Chen
Journal:  Front Bioeng Biotechnol       Date:  2020-07-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.